Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This framework explains why some patients see dramatic improvements while others see modest changes
Regardless of the protocol chosen, all patients should limit use to 90 consecutive days , followed by a 30-day washout period
Real-world data is more mixed and depends heavily on consistent dosing
What ultimately may hold more promise for less well-resourced patients in either Medicaid or the program for the elderly and certain disabled groups, Medicare, are the agreements Novo Nordisk and Eli Lilly reached with the Trump administration on selling GLP-1 treatments for $245 a month to the public insurers
Coverage depends on your insurance company, pharmacy benefits, diagnosis, BMI, medical necessity, and prior authorization requirements
US$ 21.45
US$ 29.49
US$ 20.24
US$ 23.46
US$ 22.56
US$ 28.37
US$ 21.05
